XML 55 R42.htm IDEA: XBRL DOCUMENT v3.22.1

SHAREHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2021

Stockholders' Equity Note [Abstract]

Schedule of Assumptions Used to Determine Fair Value of Options Granted

The fair value of the Company's stock options granted to employees and directors for the years ended December 31, 2021, 2020 and 2019 was estimated using the following assumptions:

			2021						2020						2019
Expected volatility			26.21%-27.87%						0.00%-25.79%						19.44%-21.54%
Risk free interest rate			0.30%-0.93%						0.00%-0.86%						1.43%-2.55%
Expected dividend			$	—					—						—
Expected term (in years)			3.5						3.5						3.5

Schedule of Stock Option Activity

A summary of the Company's stock options activity and related information for the year ended December 31, 2021, is as follows:

			Number of options						Weighted-average exercise price						Weighted- average remaining contractual term (in years)						Aggregate intrinsic value
Outstanding at January 1, 2021			988,374						22.49						4.26						258,014
Granted			437,610						12.80
Exercised			232,376						18.41
Cancelled			326						39.52
Forfeited			84,630						0.46
Outstanding at December 31, 2021			1,108,652						21.20						4.42						313,083
Exercisable at December 31, 2021			375,521						54.57						3.14						93,516

Schedule of Options Outstanding by Exercise Price Range

The options outstanding under the Company's stock option plans as of December 31, 2021 have been separated into ranges of exercise price as follows:

Ranges of exercise price									Options outstanding as of December 31, 2021						Weighted average remaining contractual term						Weighted average exercise price						Options Exercisable as of December 31, 2021						Weighted average exercise price of options exercisable
															(Years)						$												$
$			0.27 - 0.31						951,076.0						4.57						0.29						230,960.0						0.3
$			6.72 - 8.57						1,820.0						2.13						7.03						1,820.0						7.0
$			20.44- 24.99						3,019.0						5.97						21.84						2,744.0						21.5
$			37.21 - 54.51						4,584.0						4.43						45.66						3,632.0						43.4
$			57.10 - 85.14						30,968.0						1.51						79.53						30,968.0						79.5
$			96.74						24,891.0						2.37						96.74						24,891.0						96.7
$			151.63 - 224.18						68,718.0						4.14						183.22						68,718.0						183.2
$			232.2						23,576.00						5.32						232.20						11,788.00						232.20
									1,108,652						4.42						21.20						375,521						54.57

Schedule of Restricted Stock Units Activity

A summary of the Company's RSU and the Company's RSA activities and related information for the year ended December 31, 2021, is as follows:

			Number of RSU and RSA (*)
Outstanding at January 1, 2021			1,463,687
Granted			750,155
Vested			(485,124)
Forfeited			(119,709)
Outstanding at December 31, 2021			1,609,009

(*) NIS 1.0 par value, which represents approximately $0.32.

Schedule of Allocated Share-Based Compensation Expense

The total equity-based compensation expense related to all of the Company's equity-based awards recognized for the years ended December 31, 2021, 2020 and 2019 was comprised as follows:

			Year ended December 31,
			2021						2020						2019
Cost of revenues			$	17,880					$	11,313					$	11,244
Research and development, net			28,558						13,668						9,239
Selling and marketing			42,021						30,262						26,650
General and administrative			67,914						48,221						34,897
Total stock-based compensation expenses			$	156,373					$	103,464					$	82,030

X

- Definition

Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration